FDA Approves Opdivo (nivolumab) with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Read more
PURIFY’22 – Chromatography Purification Conclave Promises to Provide Unprecedented Knowledge and Networking Opportunities Read more
BeiGene Announces Health Canada Approval for BRUKINSA (zanubrutinib) in Relapsed or Refractory Marginal Zone Lymphoma Read more
Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S. Read more
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Read more
Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing Read more
Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome Read more